Key facts
- Sonrai Analytics’s last known valuation is $15.1M (Apr 2025).
- It has raised $6.3M; the latest was PE Growth/Expansion in Sep 2025.
- Notable investors include Innovate UK, Molten Ventures, Techstart Ventures, Clarendon Fund Managers, Invest Northern Ireland — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Sonrai Analytics
- ·The full record, as it builds
Funding rounds
No funding rounds for Sonrai Analytics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sonrai Analytics
Developer of analytics software designed to elevate data, discover new treatments, or expedite research development. The company's software integrates multi-omic data, advanced AI analytics, and a secure infrastructure for accelerated drug candidate identification and biomarker discovery, enabling precision medicine organizations to streamline research, reduce time-to-market, and improve patient outcomes.
- Sector
- Information Technology
- HQ
- Belfast, United Kingdom
- Founded
- 2018
- Employees
- 39
- Website
- sonraianalytics.com/
- Ownership
- Privately Held (backing)
Sonrai Analytics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sonrai Analytics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sonrai Analytics in its N-PORT filings yet. We sweep new filings monthly.